Clinical Trials Browser

Phase 2 × Bone Neoplasms × pembrolizumab × Clear all

NCT02301039 2020-09-29

SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas

Phase 2 Completed

144 enrolled 16 charts

Bone Neoplasms, Sarcoma